Vemurafenib is a medicine used to treat patients with melanoma-like skin cancer that does not improve with other types of treatment or has metastases in other organs. The drug proved to be effective, even in cases of malignant cancers with metastasis, due to its action of neutralizing the cellular mutation.
In order to use this medicine, it is also necessary that the cancer be caused by the mutation in the BRAF V600 gene, because it is this mutation that the drug can prevent, decreasing the degree of cancer development. Thus, to start the treatment it is necessary to have a blood test to confirm the change, before starting the treatment.
Vemurafenib is produced by Roche Pharma, under the trade name Zelboraf, in 240 mg tablet boxes.
Price
The price of Vemurafenib varies according to the place of purchase, however it costs, on average, 8 thousand reais per box of 56 tablets.
Who can take
This medicine is indicated for the treatment of melanoma positive for the BRAF V600 mutation, metastatic or with difficult treatment.
How to use
Treatment for any type of cancer should be guided by an oncologist, depending on the evolution of the disease and the patient's history. However, in most cases, treatment with Vemurafenib is done with 4 240 mg tablets, twice a day, until your doctor tells you to.
What side effects
The main side effects of this remedy include decreased appetite, headaches, constant coughing, diarrhea, vomiting, nausea, constipation, joint pain, excessive tiredness and muscle aches.
Who should not take
Vemurafenib is contraindicated in patients with hypersensitivity to the active substance or to any of the ingredients.
Know all the options available for the treatment of skin cancer.